Page 5 The PinPointTest, a Machine Learning-based test for Cancer in symptomatic patients. Dr Nigel Sansom PinPoint Data Science ‘PinPoint Data Science has for the last six years been developing ‘The PinPoint Test’, an AI Machine Learning-based blood test for cancer. It comprises regulated software medical devices for nine NHS urgent cancer referral pathways and is designed to assist clinicians by providing the risk that a given patient has cancer. It is affordable, cost-effective, and has been deployed in the NHS for service evaluation since 2020. Because the core technology of the PinPoint Test is a combination of machine learning and statistical modelling, it is possible to use improved training data sets to produce new versions of the test with improved diagnostic accuracy performance. Such improved data sets arise naturally from use of the test, and post-market surveillance (clinical follow-up). In partnership with the West Yorkshire and Harrogate Cancer Alliance and the broader NHS West Yorkshire ICS, the recent service evaluation has produced promising results for the Lower GI, Breast, Urological and Skin urgent pathways for symptomatic patients. PinPoint is now working with NHS partners to clinically deploy the test, and through continual improvement as we collect more and more data, will look to move the dial on early detection’. Dr Nigel Sansom Originally trained in molecular pathology, Nigel has over twenty year’s-experience of senior level roles in the pharmaceutical and biotech industries, academia, consultancy and the NHS. He has developed an international reputation for his involvement in innovation and the commercial development of medical technology and diagnostics having been one of the founding managers of the NHS National Innovation Centre. Nigel advises governmental grant awarding bodies on life sciences, and medical technology, and has been a mentor to participants in numerous technology accelerators. He joined the founders’ team at PinPoint Data Science in 2017 as Executive Chair and as part of the Business Team, Nigel plays an active role in helping the company develop a Machine Learning-based blood test for cancer.
RkJQdWJsaXNoZXIy NDMyMTY=